Aplastic anemia | Symptoms, Risk Groups & Treatment Options Page 5

 Home > Drugs > Aplastic anemia

Aplastic anemia

Aplastic anemia (AA) is a disease in which the bone marrow hematopoietic stem cells and the bone marrow microenvironment are severely damaged by physical, chemical, biological or unknown factors, resulting in a decrease or failure of the bone marrow hematopoietic function. It is a group of syndromes with pancytopenia as the main manifestation. According to a survey in 21 provinces (cities) and autonomous regions in China, the annual incidence rate is 0.74/100,000 population, which is significantly lower than the incidence rate of leukemia; the incidence rate of chronic aplastic anemia is 0.60/100,000 population, and the incidence rate of acute aplastic anemia is 0.14/100,000 population; it can occur in all age groups, but it is more common in young and middle-aged people; the incidence rate in men is slightly higher than that in women.

Site of disease:

Bone marrow blood vessels
Infectious :

Not contagious
Frequent population:

Young adults, mostly males
Related symptoms:

Gastrointestinal bleeding retinal bleeding and exudation visceral bleeding bleeding tendency fatigue

Indication: 1. Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2. Promote the increase of neutrophil count after bone marrow transplantation. 3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, and cyclical neutropenia.

Manufacturer:

CSPC Baike (Shandong) Bio-Pharmaceutical Co., Ltd.

Recombinant human granulocyte-stimulating factor injection

Indication: 1 Neutropenia caused by cancer chemotherapy and other reasons; cancer patients use bone marrow suppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy drugs, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the duration of agranulocytosis, accelerate the recovery of granulocyte count, and thus reduce the risk of concurrent infection and fever. 2 Promote the increase of neutrophil count after bone marrow transplantation. 3 Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital and idiopathic neutropenia, myelodysplastic syndrome with neutropenia, cyclical neutropenia

Manufacturer:

Changchun GeneScience Pharmaceutical Co., Ltd.

Aminopeptide tablets